PCB:NASDAQPCB Bancorp Analysis
Data as of 2026-04-23 - not real-time
$23.87
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: PCB is trading at $23.87, comfortably above its 20‑day (23.54), 50‑day (22.80) and 200‑day (21.96) simple moving averages, indicating a bullish trend. The RSI sits at 57, showing neutral‑to‑slightly bullish momentum, while the MACD histogram has turned marginally negative, hinting at a short‑term pause. Volume is increasing, support sits around $21.82 and resistance near $24.99, and the stock’s 30‑day volatility is a brisk 21% with a beta under 0.9, suggesting lower market‑wide risk. The market sentiment is extremely greedy (Fear‑Greed Index 86.95), which may be pricing in optimism.
Fundamental outlook: Valuation appears attractive – a trailing P/E of 9.3 versus the industry average of 17.5, and a price‑to‑book of just 1.05. Revenue is growing 16% YoY, operating margins are robust at 46.7%, and net profit margin is 33.5%. The balance sheet is strong with $207 M cash against $53 M debt, and the dividend yield of 3.42% is supported by a modest 31% payout ratio. Forward earnings imply an even lower forward P/E of 7.8, underscoring potential upside.
Fundamental outlook: Valuation appears attractive – a trailing P/E of 9.3 versus the industry average of 17.5, and a price‑to‑book of just 1.05. Revenue is growing 16% YoY, operating margins are robust at 46.7%, and net profit margin is 33.5%. The balance sheet is strong with $207 M cash against $53 M debt, and the dividend yield of 3.42% is supported by a modest 31% payout ratio. Forward earnings imply an even lower forward P/E of 7.8, underscoring potential upside.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price is near short‑term resistance around $24.99
- MACD histogram has turned slightly negative
- Strong dividend yield of 3.42% provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth of 16% YoY and operating margin above 45%
- Valuation discount to peers (P/E 9.3 vs industry 17.5)
- Solid cash position and low debt enhances financial stability
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair‑value estimate suggests significant upside
- Low beta and consistent dividend support defensive profile
- Sustained profitability and capital strength for future growth
Key Metrics & Analysis
Financial Health
Revenue Growth16.30%
Profit Margin33.53%
P/E Ratio9.3
ROE9.94%
ROA1.18%
P/B Ratio1.1
Op. Cash Flow$26.6M
Industry P/E17.5
Technical Analysis
TrendBullish
RSI57.3
Support$21.82
Resistance$24.99
MA 20$23.54
MA 50$22.80
MA 200$21.96
MACDBearish
VolumeIncreasing
Fear & Greed Index86.95
Valuation
Fair Value$45.63
Target Price$25.25
Upside/Downside5.78%
GradeUndervalued
TypeBlend
Dividend Yield3.42%
Risk Assessment
Beta0.82
Volatility21.25%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.